SAN JUAN, Puerto Rico -- The investigational antibody-drug conjugate sacituzumab tirumotecan plus pembrolizumab (Keytruda) ...
Waters BD Onclarity HPV assay is intended to remove barriers that prevent individuals from receiving routine cervical cancer ...
We searched PubMed, Cochrane, CancerLit, Google Scholar, medRxiv, bioRxiv, UpToDate, TRIP database, and the ProQuest Dissertations and Theses Global databases to identify relevant articles. We ...
Waters Corporation (NYSE: WAT) today announced that the U.S. Food and Drug Administration (FDA) has cleared the Onclarity HPV ...
April 8 (Reuters) - Lab equipment maker Waters said on Wednesday the U.S. Food and Drug Administration has cleared its ...
Carlsmed (NASDAQ:CARL) used its presentation at Needham’s 25th Annual Healthcare Conference to highlight progress in its ...
Cervical myelopathy is a condition that compresses your spinal cord. This happens due to narrowing or pressure in your cervical spine, or the neck region of your backbone. This condition is the most ...
A lower CD4 count is associated with a higher risk for cervical carcinoma in situ and cervical cancer in women with HIV ...
Cervical cancer may be more common in people over 60 years old than originally believed. However, current screenings suggest that individuals over the age of 65 no longer receive regular cervical ...
Degenerative cervical spondylosis is a chronic, progressive deterioration of osseocartilaginous components of the cervical spine that is most often related to aging. Radiographic evidence of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results